Recently the stock shares of cancer drug companies have shot up due to the recent discoveries and progress of cancer research. Specifically, the cancer research company Day One Bio, made a breakthrough in cancer therapy for brain tumors. As a result, the stock shares have increased from 21.3 cents to $16.54. Other cancer research companies have also showed promising results in treating different types of cancer. ImmunoGen Inc’s shares went up from 7.7 cents to $15.48 after they found a 35 percent reduction in tumor progression from a drug they created.
As we see significant progress being made in the field of cancer research, investors are more optimistic about the future, and cancer patients are hopeful that more breakthroughs will be made. Part of these recent breakthroughs that have been evident in stock shares going up for cancer drug companies and has also brought public awareness to the different types of cancer. With that, more people will start to invest in cancer research, further progressing the timeline to finding a cure.
Cancer research and progress can be attributed to a collective effort from drug companies, education, and the government all working together to find a solution. When they work together, it accelerates the research process, funding, and spreads awareness so that there is a better understanding of why cancer can be so deadly.
As a result, drug agencies have actively made an effort to expedite the process of approving different therapies and cancer-related drugs. When companies get official approvals from the FDA for therapy or a new drug, it results in more investors. With both companies and individual donors on the rise, it has created a domino effect of investors putting their money into cancer research. Right now, cancer research has been the spotlight in the healthcare industry, and with increased efforts to raise awareness and donations for the cause, it will continue to move stock prices up.
